Group T, Akullian A, Akulu R, Aliyu G, Anam F, Guichard A, Ayles H, Baggaley R, Bansi-Matharu L, Baptiste S, Bershteyn A, Cambiano V, Carter A, Chotun N, Citron D, Crowley S, Dalal S, Edun O, Fraser C, Galvani A, Garnett G, Glabius R, Godfrey-Faussett P, Grabowski M, Gray G, Hargreaves J, Imai-Eaton J, Johnson L, Kaftan D, Kagaayi J, Kataika E, Kilonzo N, Kirungi W, Korenromp E, Kouton M, Abeler-Dörner L, Mahy M, Mangal T, Martin-Hughes R, Matsikure S, Meyer-Rath G, Mishra S, Mmelesi M, Mohammed A, Moolla H, Morrison M, Moyo S, Mudimu E, Mugabe M, Murenga M, Ng'ang'a J, Olaifa Y, Phillips A, Pickles M, Probert W, Ramaabya D, Rautenbach S, Revill P, Shakarishvili A, Sheneberger R, Smith J, Stegling C, Stover J, Tanser F, Taramusi I, Brink D, Whittles L, Zaidi I. The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa. The Lancet 2024, 404: 638-641. PMID: 38782003, DOI: 10.1016/s0140-6736(24)00980-2.Peer-Reviewed Original Research